Pancreatic Cancer Research

ResearcherIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"No recent work listed

Salvatore Tafuto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3019-354X; OpenAlex author ID A5012373998. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 4

  1. Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. Co-author DOI 10.3390/jcm10061305↗
  2. Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials. Last author DOI 10.1080/0284186x.2017.1288922↗
  3. Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples. Last author DOI 10.21873/anticanres.11539↗
  4. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Co-author DOI 10.1016/j.ijsu.2015.04.095↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Antonio Avallone · 3 shared papers, 2017–2021 · strength 0.26
  2. Raffaéle Palaia · 2 shared papers, 2015–2021 · strength 0.16
  3. Vincenza Granata · 2 shared papers, 2015–2021 · strength 0.16
  4. Antonella Petrillo Petrillo · 2 shared papers, 2015–2021 · strength 0.16
  5. Francesco Izzo · 2 shared papers, 2015–2021 · strength 0.16
  6. Alessandro Ottaiano · 2 shared papers, 2017 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.